How Brainin was paid
$3.6M in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Total |
|---|---|---|---|---|
| Robert BraininChief Executive Officer | $346,154 | — | $3,220,868 | $3,567,022 |
| Ronnie MorrisChief Executive Officer | $233,333 | — | — | $233,333 |
| David MillerChief Financial Officer | $315,000 | $25,000 | $48,464 | $388,464 |
| Brady DavisPresident | — | — | — | — |
What changed and why
- $3.6M$3,567,022 was Robert Brainin’s 2026 total compensation, including $3,220,868 in option awards.
- $233K$233,333 was Ronnie Morris’s 2026 total compensation after serving as CEO for part of the year.
- $388K$388,464 was David Miller’s 2026 total compensation, including a $25,000 bonus and $48,464 in options.
- 75%75% of base salary was Brainin’s discretionary target incentive bonus opportunity.
- 700,000 options were granted to Brainin under his employment agreement, with time- and performance-based vesting.
- Brady Davis received no 2026 compensation after his prior-year death and forfeiture of unvested equity awards.
Other Champions Oncology proxy statements
- 2025 proxy statement
Ronnie Morris paid $600,000 (+50% on the year).
Filed Aug 22, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.